nach oben

Erschienen in:

01.03.2014 | Original Paper

Effect of the BDNF Val66Met Polymorphism on Regional Gray Matter Volumes and Cognitive Function in the Chinese Population

verfasst von: Mu-En Liu, Chu-Chung Huang, Mu-Hong Chen, Albert C. Yang, Pei-Chi Tu, Heng-Liang Yeh, Chen-Jee Hong, Jin-Fan Chen, Jen-Ping Hwang, Ching-Po Lin, Shih-Jen Tsai

Erschienen in: NeuroMolecular Medicine | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is common and influences the activity-dependent secretion of BDNF, which is critical for neuronal plasticity and survival. This study investigated the genetic effect of the BDNF Val66Met polymorphism on cognitive function and regional gray matter (GM) volume in a healthy Chinese population (n = 330). Voxel-based morphometry (VBM)-optimized analysis was used. There was no significant difference in the neuropsychological performances among the three BDNF genotypic groups. VBM analyses demonstrated that Met homozygotes had greater GM volumes than Val homozygotes in the left medial frontal gyrus, the left middle temporal gyrus, the left cerebellum, and the right middle temporal gyrus, and had larger GM volumes than Val/Met heterozygotes in the left middle temporal gyrus, the left inferior temporal gyrus, and the right superior frontal gyrus. Our findings suggest that the presence of two Met alleles has a protective effect on regional GM volumes in the Chinese population.

Aicardi, G., Argilli, E., Cappello, S., Santi, S., Riccio, M., Thoenen, H., et al. (2004). Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain derived neurotrophic factor. Proceedings of the National Academy of Sciences of the United States of America, 101(44), 15788–15792.CrossRefPubMedCentralPubMed

Ashburner, J. (2007). A fast diffeomorphic image registration algorithm. Neuroimage, 38(1), 95–113.CrossRefPubMed

Ashburner, J., & Friston, K. J. (2000). Voxel-based morphometry–the methods. Neuroimage, 11(6 Pt 1), 805–821.CrossRefPubMed

Ashburner, J., & Friston, K. J. (2005). Unified segmentation. Neuroimage, 26(3), 839–851.CrossRefPubMed

Bueller, J. A., Aftab, M., Sen, S., Gomez-Hassan, D., Burmeister, M., & Zubieta, J. K. (2006). BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biological Psychiatry, 59(9), 812–815.CrossRefPubMed

Carballedo, A., Amico, F., Ugwu, I., Fagan, A. J., Fahey, C., Morris, D., et al. (2012). Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 159B(5), 537–548.CrossRef

Carballedo, A., Morris, D., Zill, P., Fahey, C., Reinhold, E., Meisenzahl, E., et al. (2013). Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162B(2), 183–190.CrossRef

Chen, Q. Y., Chen, Q., Feng, G. Y., Wan, C. L., Lindpaintner, K., Wang, L. J., et al. (2006). Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population. Neuroscience Letters, 397(3), 285–290.CrossRefPubMed

Cuadra, M. B., Cammoun, L., Butz, T., Cuisenaire, O., & Thiran, J. P. (2005). Comparison and validation of tissue modelization and statistical classification methods in T1-weighted MR brain images. IEEE Transactions on Medical Imaging, 24(12), 1548–1565.CrossRefPubMed

Dempster, E., Toulopoulou, T., McDonald, C., Bramon, E., Walshe, M., Filbey, F., et al. (2005). Association between BDNF val66 met genotype and episodic memory. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 134B(1), 73–75.CrossRef

Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112(2), 257–269.CrossRefPubMed

Gajewski, P. D., Hengstler, J. G., Golka, K., Falkenstein, M., & Beste, C. (2011). The Met-allele of the BDNF Val66Met polymorphism enhances task switching in elderly. Neurobiology of Aging, 32(12), 2327.e7–2327.e19.CrossRef

Goldberg, T. E., Iudicello, J., Russo, C., Elvevag, B., Straub, R., Egan, M. F., et al. (2008). BDNF Val66Met polymorphism significantly affects d′ in verbal recognition memory at short and long delays. Biological Psychology, 77(1), 20–24.CrossRefPubMed

Gonul, A. S., Kitis, O., Eker, M. C., Eker, O. D., Ozan, E., & Coburn, K. (2011). Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. The World Journal of Biological Psychiatry, 12(2), 110–118.CrossRefPubMed

Gorski, J. A., Balogh, S. A., Wehner, J. M., & Jones, K. R. (2003). Learning deficits in forebrain-restricted brain derived neurotrophic factor mutant mice. Neuroscience, 121(2), 341–354.CrossRefPubMed

Guo, N. W., Liu, H. C., Wong, P. F., Liao, K. K., Yan, S. H., Lin, K. P., et al. (1988). Chinese version and norms of the mini-mental status examination. Chinese Journal of Rehabilitation Medicine, 16, 52–59.

Hajek, T., Kopecek, M., & Höschl, C. (2012). Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: Meta-analysis. The World Journal of Biological Psychiatry, 13(3), 178–187.CrossRefPubMed

Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., & Egan, M. F. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. The Journal of Neuroscience, 23(17), 6690–6694.PubMed

Harris, S. E., Fox, H., Wright, A. F., Hayward, C., Starr, J. M., & Whalley, L. J. (2006). The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Molecular Psychiatry, 11(5), 505–513.CrossRefPubMed

Hofer, M., Pagliusi, S. R., Hohn, A., Leibrock, J., & Barde, Y. A. (1990). Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. The EMBO Journal, 9(8), 2459–2464.PubMed

Joffe, R. T., Gatt, J. M., Kemp, A. H., Grieve, S., Dobson-Stone, C., Kuan, S. A., et al. (2009). Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness. Human Brain Mapping, 30(4), 1246–1256.CrossRefPubMed

Kambeitz, J. P., Bhattacharyya, S., Ilankovic, L. M., Valli, I., & Collier, D. A. (2012). Effect of BDNF Met66Val-Polymorphism on declarative memory and its neural substrate: A meta-analysis. Neuroscience and Biobehavioral Reviews, 36(9), 2165–2177.CrossRefPubMed

Karnik, M. S., Wang, L., Barch, D. M., Morris, J. C., & Csernansky, J. G. (2010). BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Research, 178(2), 425–429.CrossRefPubMedCentralPubMed

Koolschijn, P. C., van Haren, N. E., Bakker, S. C., Hoogendoorn, M. L., Hulshoff Pol, H. E., & Kahn, R. S. (2010). Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus, 20(9), 1010–1017.CrossRefPubMed

Korte, M., Griesbeck, O., Gravel, C., Carroll, P., Staiger, V., Thoenen, H., et al. (1996). Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 93(22), 12547–12552.CrossRefPubMedCentralPubMed

Lang, U. E., Hellweg, R., Kalus, P., Bajbouj, M., Lenzen, K. P., Sander, T., et al. (2005). Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl), 180(1), 95–99.CrossRef

Lau, J. Y., Goldman, D., Buzas, B., Hodgkinson, C., Leibenluft, E., Nelson, E., et al. (2010). BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents. Neuroimage, 53(3), 952–961.CrossRefPubMedCentralPubMed

Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001). Regulation of cell survival by secreted proneurotrophins. Science, 294(5548), 1945–1948.CrossRefPubMed

Li, J., Yu, C., Li, Y., Liu, B., Liu, Y., Shu, N., et al. (2009). COMT val158met modulates association between brain white matter architecture and IQ. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B(3), 375–380.CrossRef

Lu, B. (2003). BDNF and activity-dependent synaptic modulation. Learning & Memory, 10(2), 86–98.CrossRef

Manjon, J. V., Coupe, P., Marti-Bonmati, L., Collins, D. L., & Robles, M. (2010). Adaptive non-local means denoising of MR images with spatially varying noise levels. Journal of Magnetic Resonance Imaging: JMRI, 31(1), 192–203.CrossRefPubMed

Meyer-Lindenberg, A., & Weinberger, D. R. (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience, 7(10), 818–827.CrossRefPubMed

Molendijk, M. L., Bus, B. A., Spinhoven, P., Kaimatzoglou, A., Voshaar, R. C., Penninx, B. W., et al. (2012). A systematic review and meta-analysis on the association between BDNF val(66) met and hippocampal volume-A genuine effect or a winners curse? American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 159B(6), 731–740.CrossRef

Montag, C., Basten, U., Stelzel, C., Fiebach, C. J., & Reuter, M. (2010a). The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans. Psychiatry Research, 179(1), 86–90.CrossRefPubMed

Montag, C., Reuter, M., Newport, B., Elger, C., & Weber, B. (2008). The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: Evidence from a genetic imaging study. Neuroimage, 42(4), 1554–1559.CrossRefPubMed

Montag, C., Schoene-Bake, J. C., Faber, J., Reuter, M., & Weber, B. (2010b). Genetic variation on the BDNF gene is not associated with differences in white matter tracts in healthy humans measured by tract-based spatial statistics. Genes, Brain and Behavior, 9(8), 886–891.CrossRef

Montag, C., Weber, B., Fliessbach, K., Elger, C., & Reuter, M. (2009). The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: Incremental support for a genetic risk factor for depression. Psychological Medicine, 39(11), 1831–1839.CrossRefPubMed

Nemoto, K., Ohnishi, T., Mori, T., Moriguchi, Y., Hashimoto, R., Asada, T., et al. (2006). The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neuroscience Letters, 397(1–2), 25–29.CrossRefPubMed

Neves-Pereira, M., Cheung, J. K., Pasdar, A., Zhang, F., Breen, G., Yates, P., et al. (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry, 10(2), 208–212.CrossRefPubMed

Oroszi, G., Lapteva, L., Davis, E., Yarboro, C. H., Weickert, T., Roebuck-Spencer, T., et al. (2006). The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 65(10), 1330–1335.CrossRefPubMed

Petryshen, T. L., Sabeti, P. C., Aldinger, K. A., Fry, B., Fan, J. B., Schaffner, S. F., et al. (2010). Population genetic study of the brain-derived neurotrophic factor (BDNF) gene. Molecular Psychiatry, 15(8), 810–815.CrossRefPubMedCentralPubMed

Pezawas, L., Meyer-Lindenberg, A., Goldman, A. L., Verchinski, B. A., Chen, G., Kolachana, B. S., et al. (2008). Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Molecular Psychiatry, 13(7), 709–716.CrossRefPubMed

Pezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., et al. (2004). The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. The Journal of Neuroscience, 24(45), 10099–10102.CrossRefPubMed

Poo, M. M. (2001). Neurotrophins as synaptic modulators. Nature Reviews Neuroscience, 2(1), 24–32.CrossRefPubMed

Rajapakse, J. C., Giedd, J. N., & Rapoport, J. L. (1997). Statistical approach to segmentation of single-channel cerebral MR images. IEEE Transactions on Medical Imaging, 16(2), 176–186.CrossRefPubMed

Ramasamy, D. P., Ramanathan, M., Cox, J. L., Antulov, R., Weinstock-Guttman, B., Bergsland, N., et al. (2011). Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study. Pathophysiology, 18(1), 53–60.CrossRefPubMed

Reitan, M., & Wolfson, D. (1985). The Halstead–Reitan neuropsychological test battery: Theory and clinical interpretation. Tucson, AZ: Neuropsychology Press.

Rosa, A., Cuesta, M. J., Fatjo-Vilas, M., Peralta, V., Zarzuela, A., & Fañanás, L. (2006). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: Evidence from a family-based association study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B(2), 135–138.CrossRef

Seidah, N. G., Benjannet, S., Pareek, S., Chretien, M., & Murphy, R. A. (1996). Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Letters, 379(3), 247–250.CrossRefPubMed

Sen, S., Nesse, R. M., Stoltenberg, S. F., Li, S., Gleiberman, L., Chakravarti, A., et al. (2003). A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology, 28(2), 397–401.CrossRefPubMed

Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (MINI.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22–33.PubMed

Studer, L., Spenger, C., Seiler, R. W., Othberg, A., Lindvall, O., & Odin, P. (1996). Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon. Experimental Brain Research, 108(2), 328–336.CrossRefPubMed

Szeszko, P. R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., et al. (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry, 10(7), 631–636.CrossRefPubMed

Takahashi, T., Suzuki, M., Tsunoda, M., Kawamura, Y., Takahashi, N., Maeno, N., et al. (2008). The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(5), 1236–1242.CrossRefPubMed

Talairach, J., & Tornoux, P. (1998). Co-planar stereotaxic atlas of the human brain: 3-Dimensional proportional system: An approach to cerebral imaging. Stuttgart: Georg Thieme.

Tan, H. Y., Chen, A. G., Chen, Q., Browne, L. B., Verchinski, B., Kolachana, B., et al. (2012). Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications. Molecular Psychiatry, 17(10), 1007–1016.CrossRefPubMedCentralPubMed

Tapia-Arancibia, L., Aliaga, E., Silhol, M., & Arancibia, S. (2008). New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Research Reviews, 59(1), 201–220.CrossRefPubMed

Tohka, J., Zijdenbos, A., & Evans, A. (2004). Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage, 23(1), 84–97.CrossRefPubMed

Tost, H., Alam, T., Geramita, M., Rebsch, C., Kolachana, B., Dickinson, D., et al. (2012). Effects of the BDNF Val66Met polymorphism on white matter microstructure in healthy adults. Neuropsychopharmacology, 38(3), 525–532.CrossRefPubMed

Tsai, S. J., Gau, Y. T., Liu, M. E., Hsieh, C. H., Liou, Y. J., & Hong, C. J. (2008). Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia. Neuroscience Letters, 433(2), 158–162.CrossRefPubMed

Ventriglia, M., Bocchio Chiavetto, L., Benussi, L., Binetti, G., Zanetti, O., Riva, M. A., et al. (2002). Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Molecular Psychiatry, 7(2), 136–137.CrossRefPubMed

Voineskos, A. N., Lerch, J. P., Felsky, D., Shaikh, S., Rajji, T. K., Miranda, D., et al. (2011). The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Archives of General Psychiatry, 68(2), 198–206.CrossRefPubMed

Willis-Owen, S. A., Fullerton, J., Surtees, P. G., Wainwright, N. W., Miller, S., & Flint, J. (2005). The Val66Met coding variant of the brain-derived neurotrophic factor (BDNF) gene does not contribute toward variation in the personality trait neuroticism. Biological Psychiatry, 58(9), 738–742.CrossRefPubMed

Yamada, K., Mizuno, M., & Nabeshima, T. (2002). Role for brain-derived neurotrophic factor in learning and memory. Life Sciences, 70(7), 735–744.CrossRefPubMed

Yang, X., Liu, P., Sun, J., Wang, G., Zeng, F., Yuan, K., et al. (2012). Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults. PLoS One, 7(6), e37777.CrossRefPubMedCentralPubMed

Yu, H., Zhang, Z., Shi, Y., Bai, F., Xie, C., Qian, Y., et al. (2008). Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. The Journal of Clinical Psychiatry, 69(7), 1104–1111.CrossRefPubMed

Titel: Effect of the BDNF Val66Met Polymorphism on Regional Gray Matter Volumes and Cognitive Function in the Chinese Population
verfasst von: Mu-En Liu
Chu-Chung Huang
Mu-Hong Chen
Albert C. Yang
Pei-Chi Tu
Heng-Liang Yeh
Chen-Jee Hong
Jin-Fan Chen
Jen-Ping Hwang
Ching-Po Lin
Shih-Jen Tsai
Publikationsdatum: 01.03.2014
Verlag: Springer US
Erschienen in: NeuroMolecular Medicine / Ausgabe 1/2014
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-013-8265-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

RE: Hernandez, R., Blanco, S., Peragon, J., Pedrosa, J. A., & Peinado, M. A. (2012). Hypobaric Hypoxia and Reoxygenation Induce Proteomic Profile Changes in the Rat Brain Cortex. Neuromolecular Medicine, doi:10.1007/s12017-012-8197-7

Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease

Selective Serotonin 3 Receptor Antagonist Treatment for Schizophrenia: Meta-analysis and Systematic Review

Complex Multilocus Effects of Catechol-O-Methyltransferase Haplotypes Predict Pain and Pain Interference 6 Weeks After Motor Vehicle Collision

Role of Histone Lysine Methyltransferases SUV39H1 and SETDB1 in Gliomagenesis: Modulation of Cell Proliferation, Migration, and Colony Formation